Narcolepsy — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for narcolepsy. 35 active patents protecting 3 drugs from 2+ originators. First major cliff: 2032. Daily refresh.

3
Approved drugs
35
Active US patents
54/100
Avg vulnerability
$172M
Annual revenue covered

Originators in Narcolepsy

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Azurity 14 patents Novartis 9 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating narcolepsy. Each bar = one year. Y-axis scaled to peak year (14 patents).

6
32
8
33
14
37
3
38

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Amphetamine Sulfate
AMPHETAMINE SULFATE
 Azurity 14 51 $172M 2037-03-10
DEXTROAMPHETAMINE — 12 57 — 2033-10-24
Ritalin
methylphenidate
 Novartis 9 54 — 2032-06-28

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11896562 Amphetamine Sulfate method of use 75 2037-03-10
11896562 Amphetamine Sulfate method of use 75 2037-03-10
11896562 Amphetamine Sulfate method of use 75 2037-03-10
11896562 Amphetamine Sulfate method of use 75 2037-03-10
9456993 DEXTROAMPHETAMINE method of use 70 2033-10-24
9456993 DEXTROAMPHETAMINE method of use 70 2033-10-24
9456993 DEXTROAMPHETAMINE method of use 70 2033-10-24
9456993 DEXTROAMPHETAMINE method of use 70 2033-10-24
11166947 Ritalin method of use 70 2038-01-25
11166947 Ritalin method of use 70 2038-01-25

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
11160772 Amphetamine Sulfate formulation 42 2037-03-10
11160772 Amphetamine Sulfate formulation 42 2037-03-10
10441554 Amphetamine Sulfate formulation 42 2037-03-10
10441554 Amphetamine Sulfate formulation 42 2037-03-10
11160772 Amphetamine Sulfate formulation 42 2037-03-10
10441554 Amphetamine Sulfate formulation 42 2037-03-10
10441554 Amphetamine Sulfate formulation 42 2037-03-10
11160772 Amphetamine Sulfate formulation 42 2037-03-10
11160772 Amphetamine Sulfate formulation 42 2037-03-10
10441554 Amphetamine Sulfate formulation 42 2037-03-10

Related